Pieter van der Meer - Gilde Healthcare

team
Venture&Growth

All team members
Pieter van der Meer
Managing Partner
The Netherlands

Pieter van der Meer

Managing Partner

Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and fundraising of the healthcare Venture & Growth and Private Equity funds.

Pieter is a Dutch national and speaks English and Spanish. He holds a Master’s degree in Chemistry from Leiden University specializing in bio-organic synthesis and molecular modeling. Pieter led investments in Ablynx, Acacia Pharma, Agendia, Inpharmatica, BG Medicine, Lumicks Technologies and NightBalance.

Pieter currently serves on the board of life sciences tools company Lumicks Technologies. In addition, he was involved with several exits and represented Gilde on the boards of antibody company Ablynx (BRU:ABLX), specialty pharma group Acacia Pharma (BRU: ACPH) and molecular diagnostics company BG Medicine (NASD:BGMD) until their respective listings at Euronext and NASDAQ. He was also board member of sleep apnea company NightBalance until it was acquired by Philips Healthcare.

Nellie Ingram

Executive Assistant
Nellie joined Gilde Healthcare in September 2022 and supports the team members of Gilde Healthcare US. Prior to joining Gilde, Nellie worked for four years at Longfellow Real Estate Partners, LLC, where she worked as...

Zosia van Eesteren

Analyst
Zosia van Eesteren is a Dutch national who joined Gilde in 2022. She focuses on the Therapeutics sector and is responsible for analyzing both private and publicly traded companies. She is involved in the identification,...

Geoff Pardo

General Partner Healthtech
Venture&Growth
Geoff Pardo joined Gilde Healthcare in 2011 as a Partner working out of the office in Boston/Cambridge, MA and is focusing on Gilde's investments in North America. He led the investments in Inari Medical (NASDAQ:...